GNTAGenenta Science S.p.A.

Nasdaq genenta.com


$ 3.15 $ 0.11 (3.45 %)    

Wednesday, 15-May-2024 09:54:02 EDT
QQQ $ 454.82 $ 2.42 (0.54 %)
DIA $ 398.57 $ -1.29 (-0.33 %)
SPY $ 530.36 $ 0.43 (0.08 %)
TLT $ 91.26 $ 1.15 (1.27 %)
GLD $ 225.37 $ 1.92 (0.89 %)
$ 3.3
$ 3.15
$ 0.00 x 0
$ 0.00 x 0
$ 3.15 - $ 3.15
$ 2.20 - $ 6.81
1,475
na
60.12M
$ 0.33
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-genenta-science-maintains-25-price-target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Genenta Science (NASDAQ:GNTA) with a Buy and maintains $25 price...

 why-urban-outfitters-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Urban Outfitters, Inc. (NASDAQ: URBN) dipped during Wednesday’s session after the company reported third-quarter fina...

 roth-mkm-assumes-genenta-science-at-buy-announces-price-target-of-15

Roth MKM analyst Kumaraguru Raja assumes Genenta Science (NASDAQ:GNTA) with a Buy rating and announces Price Target of $15.

 genenta-reported-fy22-net-loss-of-85m-compared-to-55m-in-2021

Genenta had a tax credit with a carrying value of €6.4 million and cash and cash equivalents of €29.8 million sufficient to all...

 fda-grants-orphan-drug-designation-to-genenta-sciences-temferon-for-treatment-of-glioblastoma-multiforme

Temferon is a proprietary cell therapy designed to reprogram the tumor microenvironment by delivering immunomodulatory molecule...

 hc-wainwright--co-reiterates-buy-on-genenta-science-maintains-25-price-target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Genenta Science (NASDAQ:GNTA) with a Buy and maintains $25 price...

 ef-hutton-initiates-coverage-on-genenta-science-with-buy-rating-announces-price-target-of-15

EF Hutton analyst Tony Butler initiates coverage on Genenta Science (NASDAQ:GNTA) with a Buy rating and announces Price Targ...

 why-tuesday-morning-shares-tumbled-31-here-are-66-biggest-movers-from-yesterday

Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 101.3% to settle at $0.5558 on Monday after the company announce...

 why-ventyx-biosciences-is-trading-higher-by-70-here-are-46-stocks-moving-in-mondays-mid-day-session

Gainers Ventyx Biosciences, Inc. (NASDAQ: VTYX) shares jumped 70.4% to $39.37 after Oppenheimer maintained an Outperform ra...

 why-shiftpixy-surged-around-177-here-are-71-biggest-movers-from-yesterday

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 176.5% to close at $31.00 on Thursday after the company announced plans...

 why-bilibili-is-trading-lower-by-over-around-14-here-are-50-stocks-moving-in-thursdays-mid-day-session

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 73.8% to $19.48 after the company announced plans to spin-off ShiftPixy...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION